Demonstration of a pulsing liquid hydrogen/liquid oxygen thruster

Successful operation of a pulsing liquid hydrogen/liquid oxygen attitude control propulsion system thruster (1250 lb sub f) at cryogenic inlet conditions while maintaining high specific impulse and low impulse bit capability was demonstrated. Significant technical advances and departures from conventional injector design practices were necessary in order to achieve an operable thruster. These advancements were achieved through extensive analyses of heat transfer and injector manifold priming that established the baseline feasibility for an actual hardware design. The primary subject of this paper is the result of experimental evaluation of the 45 R hydrogen inlet temperature injector concept. The test matrix consisted of 66 hot firing tests in a heat sink thrust chamber

Stability diagram of colliding beams

The effect of the beam-beam interactions on the stability of impedance mode is discussed. The detuning is evaluated by the means of single particle tracking in arbitrarily complex collision configurations, including lattice non-linearities, and used to numerically evaluate the dispersion integral. This approach also allows the effect of non-Gaussian distributions to be considered. Distributions modified by the action of external noise are discussed.Comment: 5 pages, contribution to the ICFA Mini-Workshop on Beam-Beam Effects in Hadron Colliders, CERN, Geneva, Switzerland, 18-22 Mar 201

Evaluation and demonstration of the use of cryogenic propellants /oxygen/hydrogen/ for reaction control systems. Volume 2 - Experimental evaluations and demonstration Final report

Evaluation and demonstration of cryogenic propellant /oxygen-hydrogen/ use for spacecraft reaction control system

Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements

The recent discovery that the activation domains of transcriptional activators (e.g., GAL4) from a number of species are interchangeable has led to the concept of a general mechanism for activation of RNA polymerase II genes. We have examined the different activities of the SV40 octamer motif ATGCAAAG in B cells and in HeLa cells in the context of either the beta-globin promoter, a TATA-box-containing mRNA promoter, or the U2 snRNA promoter, which contains a snRNA-specific proximal element. In the context of the beta-globin promoter, the octamer motif is a B-cell-specific enhancer element, whereas it is a ubiquitous enhancer element for the U2 snRNA promoter. The U2 promoter is unique in that it is not activated by enhancer elements that activate the beta-globin promoter, and a hybrid U2 promoter containing the upstream activating sequence UASG is not stimulated by a yeast GAL4 trans-activator. Together, these observations suggest that in the context of the U2 promoter, the octamer motif defines a new class of RNA polymerase II enhancer elements, which bind transcription factors that trans-activate gene expression by a different mechanism than the general mechanism mentioned above. These results are discussed in light of the possibility that the ubiquitous octamer binding protein Oct-1 and the B-cell-specific octamer binding protein Oct-2 are involved in the activation of the U2 and beta-globin promoters, respectively

Temporal Variability of Urinary Phthalate Metabolite Levels in Men of Reproductive Age

Phthalates are a family of multifunctional chemicals widely used in personal care and other consumer products. The ubiquitous use of phthalates results in human exposure through multiple sources and routes, including dietary ingestion, dermal absorption, inhalation, and parenteral exposure from medical devices containing phthalates. We explored the temporal variability over 3 months in urinary phthalate metabolite levels among 11 men who collected up to nine urine samples each during this time period. Eight phthalate metabolites were measured by solid-phase extraction–high-performance liquid chromatography–tandem mass spectrometry. Statistical analyses were performed to determine the between- and within-subject variance apportionment, and the sensitivity and specificity of a single urine sample to classify a subject’s 3-month average exposure. Five of the eight phthalates were frequently detected. Monoethyl phthalate (MEP) was detected in 100% of samples; monobutyl phthalate, monobenzyl phthalate, mono-2-ethylhexyl phthalate (MEHP), and monomethyl phthalate were detected in > 90% of samples. Although we found both substantial day-to-day and month-to-month variability in each individual’s urinary phthalate metabolite levels, a single urine sample was moderately predictive of each subject’s exposure over 3 months. The sensitivities ranged from 0.56 to 0.74. Both the degree of between- and within-subject variance and the predictive ability of a single urine sample differed among phthalate metabolites. In particular, a single urine sample was most predictive for MEP and least predictive for MEHP. These results suggest that the most efficient exposure assessment strategy for a particular study may depend on the phthalates of interest